ACT-709478
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 08/26/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
Actelion (J&J company) / Idorsia Pharmaceuticals Ltd.
Mechanism of Action
Ion Channel
Mechanism Description
Selective T-type Calcium Channel Blocker
Populations Tested In
Photosensitive epilepsy
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
France / Germany
Clinical Trial link